CMS Issues New Policies to Provide Greater Transparency for Medicare Advantage and Part D Plans

April 29, 2022

Today, the Centers for Medicare & Medicaid Services (CMS) issued a final rule for the Medicare Advantage (MA) and Part D prescription drug programs that will improve experiences for dually eligible beneficiaries and provide greater transparency for the MA and Part D programs. The measures set forth in the Contract Year 2023 MA and Part D Policy and Technical Changes final rule build on the agency’s strategic pillars to be a responsible steward of public programs, as it continues to expand access to quality, affordable care and advance health equity for people with Medicare and Medicaid. Read More.

Leave a Reply

Your email address will not be published.